Corden Pharma is a finished-dose manufacturer based in Italy. It holds one active US drug master file. Its filings concentrate with US FDA, MINSA (CR) and ARCSA (EC). Its GMP standing is certified by EMA, ZLG (DE) and US FDA. Its most recent recorded inspection, by US FDA, closed on 14 June 2024 as VAI. Customs aggregates show $37K of exports covering 10 molecules to 1 destination in 2022.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Plankstadt, United Arab Emirates | Not on file |
| Caponago, United Arab Emirates | Not on file |
| Switzerland, Switzerland | 3002561809 |
| Frankfurt, Germany | Not on file |
| Germany, Germany | 3012722976 |
| CAPONAGO, Italy | Not on file |
1 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| 1 | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 8 | 1 |
| MINSA (CR) | 4 | None |
| ARCSA (EC) | 3 | None |
| INVIMA (CO) | 2 | None |
| NAFDAC (NG) | 2 | None |
| DIGEMAPS (DO) | 2 | None |
| EMA | None | 4 |
| ZLG (DE) | None | 4 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2022 | Not reported | $37K | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Corden Pharma comes back tiered against every other supplier able to file there.
Start for free